Eli Lilly-Backed Scribe Therapeutics Soars 50% After Upsized IPO
Eli Lilly-backed biotech Scribe Therapeutics jumps 50% after upsized IPO, signaling renewed biotech IPO momentum.
Eli Lilly-backed biotech Scribe Therapeutics jumps 50% after upsized IPO, signaling renewed biotech IPO momentum.
Meta wins dismissal of WhatsApp privacy lawsuit, easing regulatory concerns for the social media giant.
Tesla short sellers mint $4 billion as stock nosedives amid intensifying bearish pressure on the EV giant.
Intel delivered blowout earnings but a faltering semiconductor rally is clouding the stock's near-term outlook, leaving investors cautious.
Tesla's Q2 profit fell short of analyst estimates, pressured by EV price cuts and rising R&D costs, while Elon Musk outlined a…
Tesla's Q2 earnings miss Wall Street estimates, pressuring the stock and fueling concerns over EV demand and profitability.
The S&P 500 whipsawed as investors braced for Alphabet and Tesla earnings, with tech-heavy indexes facing heightened implied volatility amid AI monetization…
EasyJet shares drop sharply after EU ownership rules review report raises concerns over airline compliance costs and market access.
Wall Street pins hopes on second-quarter earnings to revive a stalling stock rally, as economic headwinds and high valuations test investor confidence.
Tesla (TSLA) options are pricing in a historic earnings swing, with implied volatility surging ahead of the Q2 2026 report, reflecting acute…
Adobe and Salesforce face analyst downgrades amid rising fears that generative AI could erode their competitive moats, triggering a selloff in enterprise…
Short positions on US stocks reached unprecedented levels amid mounting fears that AI hype may lead to a market correction.